Subtype
Malignant Male Reproductive System Neoplasm
CI-CAN-00003180Explore in graph →
1,451 active trials27 approved drugs58 evidence items
- NCIt
- C8561
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003180Explore in graph →
Clinical trials
6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (762)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05841992 | Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients | unknown | Phase 2 / Phase 3 | 100 | Peking Union Medical College HospitalOTHER | 1 | May 3, 2023 | clinicaltrials |
| NCT04880681 | Evaluation of Length and Quality of Prostate Biopsies Taken by a New Biopsy Needle | unknown | N/A | 60 | Region SkaneOTHER | 1 | May 1, 2023 | clinicaltrials |
| NCT05246774 |
| Study of Serum and Urinary Biomarkers and Radiation Cystitis in Patients Treated With Radiotherapy for Localized Prostate Cancer(RABBIO) |
| unknown |
| — |
| 60 |
| Direction Centrale du Service de Santé des ArméesOTHER |
| 1 |
| Apr 28, 2023 |
| clinicaltrials |
| NCT05818631 | Cognitive Fusion Prostate Biopsy With Biparametric Magnetic Resonance in the Detection of Prostate Cancer | unknown | — | 300 | José Joaquín MiraOTHER | 1 | Apr 26, 2023 | clinicaltrials |
| NCT03774901 | Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile Carcinoma(PULSE) | unknown | Phase 2 | 32 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Apr 21, 2023 | clinicaltrials |
| NCT05822726 | The Combination of PSMA-PET/MR and p2PSA in Early Diagnosis of Prostate Cancer | unknown | N/A | 240 | Ruijin HospitalOTHER | 1 | Apr 21, 2023 | clinicaltrials |
| NCT02481648 | Feasibility of Measuring Exercise's Effects on Molecular Mechanisms of Disease Progression in Prostate Cancer(EMMPC) | unknown | N/A | 20 | Vancouver Prostate CentreOTHER | 1 | Apr 19, 2023 | clinicaltrials |
| NCT05737004 | Effects of Prostate Cancer on Brain Function | unknown | — | 250 | Shanghai East HospitalOTHER | 1 | Apr 19, 2023 | clinicaltrials |
| NCT05815394 | 177Lu-labeled NY108 SPECT Imaging in Patients | unknown | Early Phase 1 | 10 | Affiliated Hospital of Jiangnan UniversityOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT05816668 | Tranexamic Acid's Effects in Patients Undergoing Laparoscopic Radical Prostatectomy(Transamin) | unknown | Phase 3 | 122 | Instituto do Cancer do Estado de São PauloOTHER | 0 | Apr 18, 2023 | clinicaltrials |
| NCT05766163 | Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Prostate(COMPAR-P) | unknown | N/A | 150 | Azienda Ospedaliera Universitaria Integrata VeronaOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT04060589 | ReIMAGINE Prostate Cancer Risk | unknown | — | 1,000 | University College, LondonOTHER | 1 | Mar 22, 2023 | clinicaltrials |
| NCT05633342 | Project CADENCE (CAncer Detected Early caN be CurEd)(CADENCE) | unknown | — | 15,000 | MiRXES Pte LtdINDUSTRY | 1 | Mar 20, 2023 | clinicaltrials |
| NCT05773183 | Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men(MMetdMH) | unknown | — | 60 | Royal College of Surgeons, IrelandOTHER | 1 | Mar 17, 2023 | clinicaltrials |
| NCT01968538 | Metabolomic Study for Localized Prostate Cancer | unknown | — | 400 | Georgetown UniversityOTHER | 1 | Feb 28, 2023 | clinicaltrials |
| NCT01766492 | Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Radiosurgery(PR-PROS) | unknown | — | 200 | Georgetown UniversityOTHER | 1 | Feb 23, 2023 | clinicaltrials |
| NCT01618851 | Phase II Study to Evaluate Conventional Radiation Therapy Followed by Radiosurgical Boost in Clinically Localized Prostate Cancer | unknown | N/A | 70 | Georgetown UniversityOTHER | 0 | Feb 22, 2023 | clinicaltrials |
| NCT05403190 | The Performance of da Vinci SP System on Extraperitoneal Approach Radical Prostatectomy(CGMH-SPEAR-P) | unknown | N/A | 30 | Chang Gung Memorial HospitalOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT03756077 | A Study of the Value of Hybrid PET/MR and PET/CT in Prostate Cancer | unknown | — | 100 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Feb 14, 2023 | clinicaltrials |
| NCT05244577 | Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer | unknown | Phase 3 | 75 | Shi YanxiaOTHER | 1 | Feb 6, 2023 | clinicaltrials |
| NCT01972867 | Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients | unknown | N/A | 6 | Angiodynamics, Inc.INDUSTRY | 1 | Feb 1, 2023 | clinicaltrials |
| NCT05702619 | Hypoxia-driven Prostate Cancer Genomics (HYPROGEN)(HYPROGEN) | unknown | — | 60 | The Christie NHS Foundation TrustOTHER | 1 | Jan 27, 2023 | clinicaltrials |
| NCT05700370 | MyProstateScore Equivalency With and Without DRE | unknown | N/A | 800 | LynxDxINDUSTRY | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05533203 | Safety of Prodencel in the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC) | unknown | Phase 1 | 24 | Shanghai Humantech Biotechnology Co. LtdINDUSTRY | 1 | Jan 23, 2023 | clinicaltrials |
| NCT02759380 | Can Dietary Phytoestrogens Slow Down Prostate Tumor Proliferation?(PRODICA) | unknown | N/A | 240 | Sahlgrenska University HospitalOTHER | 1 | Jan 20, 2023 | clinicaltrials |
| NCT05690399 | Evaluation of Clinical and Pathological Characteristics and Routine Treatment of Patients With Prostate Cancer | unknown | — | 100 | Assiut UniversityOTHER | 0 | Jan 19, 2023 | clinicaltrials |
| NCT03845751 | EvaluatioN of HIFU Hemiablation and Short Term AndrogeN Deprivation Therapy Combination to Enhance Prostate Cancer Control.(ENHANCE) | unknown | Phase 2 | 20 | Institut Mutualiste MontsourisOTHER | 1 | Jan 12, 2023 | clinicaltrials |
| NCT05249712 | Efficacy and Safety of Darolutamide Combined With ADT in High-risk/Very High-risk Localized Prostate Cancer | unknown | Phase 2 | 30 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Jan 3, 2023 | clinicaltrials |
| NCT05662839 | Feasibility of Utilising Brushing Cytology and Dermoscopy for Diagnosing Penile Lesions(BRUCY) | unknown | N/A | 50 | The Christie NHS Foundation TrustOTHER | 0 | Dec 23, 2022 | clinicaltrials |
| NCT04356430 | Neoadjuvant Therapy of Abiraterone Plus ADT for High Risk Prostate Cancer | unknown | Phase 2 | 75 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Dec 16, 2022 | clinicaltrials |
| NCT02446366 | Hypofractionated Stereotactic Body Radiation Therapy for Patients With Prostate Cancer That Was Removed by Surgery | unknown | N/A | 24 | University of Southern CaliforniaOTHER | 1 | Dec 12, 2022 | clinicaltrials |
| NCT05644197 | Multidisciplinary Care After Prostatectomy(MCAP) | unknown | N/A | 100 | Provence Private hospitalOTHER | 0 | Dec 9, 2022 | clinicaltrials |
| NCT04833517 | Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study) | unknown | — | 500 | Universität des SaarlandesOTHER | 1 | Dec 8, 2022 | clinicaltrials |
| NCT05631080 | Transurethral Prostate Enucleation in Surveillance Protocol for Low Risk Prostate Cancer | unknown | Phase 4 | 50 | Mansoura UniversityOTHER | 1 | Nov 30, 2022 | clinicaltrials |
| NCT05603351 | Prostate Cancer Screening With Abbreviated MRI Protocol(ProstaPilot) | unknown | N/A | 300 | Masaryk Memorial Cancer InstituteOTHER | 1 | Nov 2, 2022 | clinicaltrials |
| NCT04457882 | Evaluation of the Safety of Intraperitoneal Laparoscopic Radical Prostatectomy With or Without Drainage Tube | unknown | N/A | 112 | Shanghai East HospitalOTHER | 1 | Oct 28, 2022 | clinicaltrials |
| NCT05025527 | Biparametric MRI in Prostate Cancer Screening: a Noninferior Randomized Controlled Study | unknown | N/A | 500 | Shanghai East HospitalOTHER | 1 | Oct 28, 2022 | clinicaltrials |
| NCT05596851 | Radio-guided Surgery With DROP-IN Beta Probe for 68Ga-PSMA, in High-risk Prostate Cancer Patients Eligible for Robotic-assisted Radical Prostatectomy. | unknown | — | 15 | European Institute of OncologyOTHER | 1 | Oct 27, 2022 | clinicaltrials |
| NCT03936127 | Comparison of a Novel Transperineal Targeted Fusion Biopsy System to Conventional Transrectal Targeted Fusion Biopsy | unknown | N/A | 360 | Dr. Nicola SchiedaOTHER | 1 | Oct 25, 2022 | clinicaltrials |
| NCT05167175 | The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutation | unknown | Phase 2 | 30 | Hongqian GuoOTHER | 1 | Oct 25, 2022 | clinicaltrials |
| NCT03482089 | Cystoprostatectomy Versus Radiotherapy Combined With ADT for the Treatment of cT4 Prostate Cancer With Bladder Invasion(CRADT) | unknown | N/A | 70 | Tongji HospitalOTHER | 1 | Oct 21, 2022 | clinicaltrials |
| NCT04026230 | Impact of Atorvastatin on Prostate Cancer Progression During ADT(ESTO2) | unknown | Phase 3 | 400 | Tampere University HospitalOTHER | 4 | Oct 21, 2022 | clinicaltrials |
| NCT03601143 | Liquid Biopsy-based Detection of Resistance to Targeted Therapy in Prostate Cancer Patients(PEARL) | unknown | — | 120 | Technical University of MunichOTHER | 1 | Oct 20, 2022 | clinicaltrials |
| NCT05179720 | The Application Research of Ultrasound Guided Puncture Stent Assisted Transperineal Prostate Biopsy | unknown | N/A | 560 | Qilu Hospital of Shandong UniversityOTHER | 1 | Oct 18, 2022 | clinicaltrials |
| NCT05179707 | A Research for Combination of Prostate Health Index (Phi) and mpMRI PI-RADS in the Diagnosis of Prostate Cancer | unknown | — | 936 | Qilu Hospital of Shandong UniversityOTHER | 1 | Oct 12, 2022 | clinicaltrials |
| NCT05432687 | Impact of Abdominal Incompetence on Urinary Incontinence After Prostatectomy (PROSTABDO)(PROSTABDO) | unknown | N/A | 80 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Oct 7, 2022 | clinicaltrials |
| NCT05572099 | ExoDx Prostate Evaluation in Active Surveillance Patient Population | unknown | — | 750 | Exosome Diagnostics, Inc.INDUSTRY | 1 | Oct 7, 2022 | clinicaltrials |
| NCT04331535 | The Genomic Medicine at VA Study(GenoVA) | unknown | N/A | 1,076 | Boston VA Research Institute, Inc.OTHER | 1 | Oct 3, 2022 | clinicaltrials |
| NCT04239599 | Trial of Hypofractionated IMRT Boost Versus Conventional IMRT Boost for Localized High Risk Prostate Cancer(RCT-PHART2) | unknown | N/A | 178 | Sunnybrook Health Sciences CentreOTHER | 0 | Sep 29, 2022 | clinicaltrials |
| NCT04245670 | 5 Fractions of Pelvic SABR With Intra Prostatic SABR Boost:(5STAR-PC) | unknown | N/A | 75 | Sunnybrook Health Sciences CentreOTHER | 1 | Sep 28, 2022 | clinicaltrials |
Data updated 23 days agoSource updated May 3, 2023source: clinicaltrials